Document Detail

Lipoprotein (a) Levels in Relation to Severity of Coronary Artery Disease in North Indian Patients.
Jump to Full Text
MedLine Citation:
PMID:  23580919     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Lipoprotein (a) [Lp (a)] is an established risk marker of coronary artery disease which is independent from other risk factors.
OBJECTIVE: The aim was to address the association between Lp (a) and CAD risk in North Indians. To evaluate whether high levels of lipoprotein (a) [Lp (a)] is a predictor of risk and is related to the severity of CAD.
MATERIALS AND METHODS: This was a cross-sectional study done on 360 patients presenting with chest pain. Coronary angiography revealed CAD in 270 patients and 90 patients without CAD. Lipoprotein (a) level, lipid profile, fasting blood glucose, anthropometric and clinical parameters were analyzed.
RESULTS: Lipoprotein (a) 21.0 mg/dL is associated with the presence of coronary lesions (P = 0.0001). A highly significant difference in Lp (a) levels was observed between normal coronaries vs. single-vessel disease, double-and triple-vessel disease ( P < 0.0001). Body mass index (BMI) was significantly raised in CAD group compared to normal coronary.
CONCLUSION: Multivariate analysis found that Lp (a) was considered an independent predictor for severity of CAD and Lp (a) levels 21.0 mg/dL are associated with severe patterns of coronary atherosclerosis.
Authors:
Fauzia Ashfaq; Pravin Kumar Goel; Rishi Sethi; Mohd Idrees Khan; Wahid Ali; Mohd Zafar Idris
Related Documents :
9874049 - Comparison of dipyridamole stress echocardiography and perfusion scintigraphy for cardi...
7441389 - The work evaluation of the cardiac patient.
2439559 - Prognostic significance of ventricular ectopic activity in survivors of acute myocardia...
8337999 - Early exercise testing after acute myocardial infarction in the elderly: clinical evalu...
15735569 - Modified mid america heart institute coronary care unit scoring system--a new comprehen...
463919 - Survival after recovery from acute myocardial infarction. two and five year prognostic ...
12718479 - Early and late outcome of stenting in a consecutive series of patients with coronary le...
9514449 - Significance of coronary artery bypass grafting-associated conduction defects.
15854919 - Aortic valve periprosthetic leakage: anatomic observations and surgical results.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Heart views : the official journal of the Gulf Heart Association     Volume:  14     ISSN:  1995-705X     ISO Abbreviation:  Heart Views     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-04-12     Completed Date:  2013-04-15     Revised Date:  2013-04-15    
Medline Journal Info:
Nlm Unique ID:  101316474     Medline TA:  Heart Views     Country:  Qatar    
Other Details:
Languages:  eng     Pagination:  12-6     Citation Subset:  -    
Affiliation:
Department of Cardiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Heart Views
Journal ID (iso-abbrev): Heart Views
Journal ID (publisher-id): HV
ISSN: 1995-705X
ISSN: 0976-5123
Publisher: Medknow Publications & Media Pvt Ltd, India
Article Information
Copyright: © Heart Views
open-access:
Print publication date: Season: Jan-Mar Year: 2013
Volume: 14 Issue: 1
First Page: 12 Last Page: 16
PubMed Id: 23580919
ID: 3621218
Publisher Id: HV-14-12
DOI: 10.4103/1995-705X.107114

Lipoprotein (a) Levels in Relation to Severity of Coronary Artery Disease in North Indian Patients
Fauzia Ashfaqaff1
Pravin Kumar Goelaff1
Rishi Sethi1
Mohd Idrees Khan2
Wahid Ali3
Mohd Zafar Idris2
Department of Cardiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India
1Department of Cardiology, King George Medical University, Lucknow, India
2Department of Community Medicine, King George Medical University, Lucknow, India
3Department of Pathology, King George Medical University, Lucknow, India
Correspondence: Address for correspondence: Ms. Fauzia Ashfaq, Department of Cardiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareli Road, Lucknow, Uttar Pradesh, India farooqui23@yahoo.co.in

INTRODUCTION

Cardiovascular diseases in India cause 3 million deaths/y, accounting for 25% of all mortality.[1] Moreover, research on Indian Asians living abroad indicates a 40% higher risk of ischemic heart disease (IHD) mortality than that for Europeans.[2]

Traditional risk factors like smoking, hypertension, and diabetes are reported to account for only 50% of the prevalence and severity of the disease.[3] The atherogenic dyslipidemic profile, especially mild to marked elevation of apo-B-containing lipoproteins, such as very low-density lipoproteins (VLDL), VLDL-remnants, intermediate-density lipoproteins (IDL), and low-density lipoproteins (LDL), and low levels of high-density lipoproteins (HDL)[46] appears to promote enhanced arterial cholesterol deposition and accelerate the progression of atherosclerotic disease.

Despite the use of new and effective pharmacological drugs to lower plasma lipid concentration, cardiovascular diseases continue to be the main cause of death in Western countries.[7, 8]

Lipoprotein (a) (Lp (a)) has emerged as a powerful genetic risk factor for coronary artery disease (CAD).[911]

Lp (a) presents a lipid composition which is similar to the composition of LDL, but with a different protein content, since it presents the apolipoprotein (a) or apo (a) linked to apolipoprotein B by disulfide bridges.[12]

In advanced atherosclerosis, Lp (a) is an independent risk factor not dependent on LDL. Lp (a) represents a coagulant risk of plaque thrombosis.[13] ApoA contains domain that are very similar to plasminogen. The main function of plasminogen is to dissolve fibrin blood clots. Lp (a) accumulates in the vessel wall and inhibits binding of plasminogen to cell surface. This inhibition of Lp (a) also promotes proliferates of smooth muscle cells. These unique features of Lp (a) suggest that it causes generation of clots and atherosclerosis.

This study aimed at investigating the existence of changes in serum levels of Lp (a) and other risk factors in patients diagnosed with CAD established on angiography, comparing them to individuals with normal angiogram to correlate possible changes with the severity of the lesion.


MATERIALS AND METHODS
Study population

A cross-sectional study was done on 360 consecutive patients (300 male, 60 female) who underwent coronary angiography between June 2008 to October 2010. The study was approved by the Institutional ethics committee. Subjects were informed on the objectives and procedure of the study and informed consent taken. The consent form was both in English and Hindi language. Demographic profile, socioeconomic status, personal habits and disease risk factor history was recorded. Blood pressure (BP) was measured at the ward before the patients were sent to catheterization laboratory. Hypertension was defined as history of hypertension or taking antihypertensive drugs at referral or systolic blood pressure > 140 mmHg or diastolic blood pressure > 90 mmHg. Those patients with known history of diabetes mellitus (DM) or with fasting glucose higher than 126 mg/dl were labeled as DM.

Inclusion criteria patients for angiography with history of chest pain, angina, previously diagnosed myocardial infarction were enrolled. Exclusion criteria subject with diseases such as nephrotic syndrome, acute or chronic renal failure, thyroid disorders, acute infections, stroke and diabetic ketoacidosis were excluded.

Angiography evaluation

Coronary angiography was performed using the Judkins technique. Coronary angiography results were evaluated byinterventional cardiologists who were blinded to the serum Lipoprotein (a) analysis.

In coronary angiography, CAD is defined as the presence of at least a > 50% stenosis of major coronary arteries (left anterior descending, left circumflex, or right coronary arteries) or their major branches (diagonal, obtuse marginal, posterior descending, or posterior left ventricular arteries).

Blood collection and analysis

Fasting blood samples were collected after 10 to 12 h before cardiac catheterization. Samples were taken in sterile tubes, centrifuged at 3000 rpm for 10 min at 4°C, and then stored at −80°C until assayed. Fasting blood glucose (FBG) level, serum total cholesterol, HDL-cholesterol (HDL-C), serum triglyceride and LDL-cholesterol (LDL-C) were estimated by standard methods.

Lipoprotein (a) estimation

Lp (a) was measured by agglutination due to an antigen – antibody reaction between Lp (a) in a sample and anti-Lp (a) antibody absorbed to latex particles.The assay range is approximately 3-90 mg/dl (Randox.Lab. Ltd U.K). Higher values of Lp (a) were again rechecked by diluting the sample by normal saline and results were standardized.


RESULTS

The mean age of the patients was 54.31(±8.35) years ranging from 30-65 years. Among 360 patients, 270 patients (75%) had angiographically proven CAD and 90 (25%) had normal coronary arteries (non-CAD group). The systolic and diastolic blood pressure was significantly ( P <0.001) higher in CAD patients as compared to non-CAD patients. The body mass index (BMI), total leukocyte count and fasting glucose were significantly ( P <0.0001) higher in CAD patients as compared to non-CAD patients.

There was a highly significant ( P <0.0001) difference in the level of triglycerides between CAD (182.76 ± 43.86 mg/dl) and non-CAD (124.14 ± 44.01 mg/dl) patients. A highly significant difference was observed in the level of VLDL between CAD (36.03 ± 9.19mg/dl) and non-CAD (24.68 ± 8.89 mg/dl) patients. However, the HDL was significantly ( P < 0.0001) lower in CAD (30.88 ± 7.52 mg/dl) patients as compared to non-CAD (40.04 ± 9.27 mg/dl) patients. The lipoprotein (a) level was significantly higher in CAD (48.73 ± 23.85 mg/dl) patients than in non-CAD patients (18.95 ± 11.15 mg/dl)[Table 1].

Comparison between diabetics and non-diabetics in diseased vessel patients

The BMI, total leukocyte count, total cholesterol, triglyceride and VLDL levels were almost similar in both diabetic and non-diabetic diseased vessel patients ( P > 0.05). However, fasting glucose was significantly ( P <0.0001) higher in diabetic diseased vessel patients as compared to non-diabetic diseased vessel patients. Similarly, serum creatinine was also significantly (P = 0.02) higher in diabetic than non-diabetic diseased vessel patients. The level of lipoprotein (a) was significantly ( P <0.0001) higher in diabetic (60.20 ± 27.72 mg/dl) than non-diabetic (44.72 ± 20.99 mg/dl) diseased vessel patients [Table 2].

Comparison of parameters by vessel grades

Total leukocyte count was significantly different (P = 0.001) among the vessel grades. The Bonferroni pairwise comparison test showed that total count was significantly (P = 0.001) different between vessel Grade 1 and 3. The total cholesterol, HDL and LDL were insignificantly different among the vessel grades ( P > 0.05). However, triglyceride (P = 0.01) and VLDL (P = 0.006) were significantly different among the vessel grades. The Bonferroni pairwise comparison test showed that both triglyceride and VLDL were significantly (P = 0.01) different between vessel Grade 1 and 3 [Table 3].

The lipoprotein (a) level was significantly ( P < 0.0001) different among normal and different vessel grades. The level was also significantly ( P < 0.0001) different from Grade 1 to 2 and 3. This was also significantly (P = 0.01) different between vessel Grade 2 and 3 [Table 4].

Half (50%) of the patients were in Tertile III followed by Tertile II (25.8%) and Tertile I (24.2%) with mean lipoprotein level of 59.90 ± 21.81 mg/dl, 29.36 ± 4.21 mg/dl and 15.53 ± 6.74 mg/dl respectively. An almost similar pattern was observed for CAD and CAD with diabetic patients [Table 5].


DISCUSSION

In our study Lp (a) levels correlated positively with severity of atherosclerosis. The most relevant finding was that Lp (a) levels 21.0 mg/dL were not only associated with the presence of coronary disease but also with the severity of the coronary atherosclerosis.

A trend towards an association between higher Lp (a) levels and severe patterns of coronary atherosclerosis has been reported.[14] Our results indicate that Lp (a) levels 21.0 mg/dL are associated with the presence of coronary disease, even when cardiovascular risk factors and specific treatments (statins and/or aspirin) were taken into account.

Results show that a high level of TG (150 mg/dl) is strongly associated with greater extent of CAD. which is in accordance with the documented epidemiologic observations reported by Melissa Austin that hypertriglyceridemia commonly occurred in CAD patients.[15] Triglyceride concentrations (130 mg/dl) had a positive predictive value of 70% to identify individuals at risk for insulin resistance[16] and insulin resistance and hypertriglyceridemia may contribute together to the increased risk of CAD in hypertension.[17] Relation between Lp (a) and coronary disease should be a constant concern and object of investigation, especially in normocholesterolemic individuals.

In conclusion, this study confirms the usefulness of Lp (a) and other risk factors to predict the severity of coronary atherosclerosis, suggesting that Lp (a) levels should be determined in patients with CAD, especially in normolipidemic individuals. Although all patients with hypertension and CAD require aggressive risk modification, the subgroup with high levels of Lp (a) and TG may designate multiple-vessel involvement and probably needs close clinical surveillance.

There are limitations to our study in that enrolled subject might not be representative of the entire population with CAD as subjects recruited were referred for coronary angiography in tertiary care hospitals.


Notes

Source of Support: Nil

Conflict of Interest: None declared

ACKNOWLEDGMENTS

We would like to acknowledge the support of the clinical biochemistry staff SGPGIMS, Lucknow for laboratory work.


REFERENCES
1. Mukherjee AK. India's health: Today and tomorrowJ Indian Med AssocYear: 19959331258713248
2. Balarajan R. Ethnicity and variations in mortality from coronary heart diseaseHealth TrendsYear: 1996284551
3. Gupta S,Johnamm A. Chlamydia pneumoniaeand CHD coincidence, association or causationBMJYear: 19973141779819224072
4. Taskinen MR. Diabetic dyslipidaemia: From basic researchto clinical practiceDiabetologiaYear: 2003467334912774165
5. Williams KJ,Tabas I. Lipoprotein retention-andclues for atheroma regressionArterioscler Thromb Vasc BiolYear: 20052515364016055756
6. Le NA,Walter MF. The role of hypertriglyceridemia in atherosclerosisCurr Atheroscler RepYear: 20079110517877919
7. Breslow JL. Cardiovascular disease burden increases, NIH funding decreasesNat MedYear: 1997360019176478
8. Braunwald E. Shattuck lecture cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunitiesN Engl J MedYear: 1997337136099358131
9. Danesh J,Collins R,Peto R. Lipoprotein (a) and coronary heart disease: A meta-analysis of prospective studiesCirculationYear: 20001021082510973834
10. Von Eckardstein A,Schulte H,Cullen P,Assmann G. Lipoprotein (a) further increases the risk of coronary events in men with high global cardiovascular riskJ Am Coll CardiolYear: 2001373439
11. Luc G,Bard JM,Arveiler D,Ferrieres J,Evans A,Amouyel P,et al. Lipoprotein (a) as a predictor of coronary heart disease: The PRIME studyAtherosclerosisYear: 20021633778412052486
12. Koschinsky ML. Lipoprotein (a) and the link between atherosclerosis and trombosisCan J CardiolYear: 2004203743
13. Caplice NM,Panetta C,Peterson TE,Kleppe LS,Mueske CS,Kostner GM,et al. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor; A novel link between lipoproteins and thrombosisBloodYear: 2001982980711698280
14. Schwartzman RA,Cox ID,Poloniecki J,Crook R,Seymour CA,Kaski JC. Elevated plasma lipoprotein (a) is associated with coronary artery disease inpatients with chronic stable angina pectorisJ Am Coll CardiolYear: 199831126069581718
15. Austin MA. Epidemiology of hypertriglyceridemia and cardiovascular diseaseAm J CardiolYear: 19998313F6F
16. McLaughlin T,Abbasi F,Cheal K,Chu J,Lamendola C,Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistantAnn Intern MedYear: 2003139802914623617
17. Reaven GM. Insulin resistance/compensatory hyperinsulinemia, essential Hypertension, and cardiovascular diseaseJ Clin Endocrinol MetabYear: 200388239940312788834

Tables
[TableWrap ID: T1] Table 1 

Comparison of clinical and biochemical parameters between coronary artery disease and non.CAD patients and as defined by angiography



[TableWrap ID: T2] Table 2 

Comparison of body mass index, hematological and biochemical parameters between diabetics and non-diabetics in diseased vessel patients



[TableWrap ID: T3] Table 3 

Comparison of hematological and biochemical parameters by vessel grades



[TableWrap ID: T4] Table 4 

Lipoprotein (a) level in normal coronary and diseased vessels



[TableWrap ID: T5] Table 5 

Lipoprotein (a) levels in different tertiles




Article Categories:
  • Original Article

Keywords: Angiography, atherosclerosis, lipoprotein (a), triglyceride.

Previous Document:  Periodontitis as risk factor for acute myocardial infarction: A case control study.
Next Document:  Snoring and risk for obstructive sleep apnea among nigerians with heart failure: Prevalence and clin...